NeuroSense Therapeutics Ltd.
NRSN | NASDAQ
$1.99
-$0.14 (-6.57%)
At close: Oct 30, 2026, 4:00 PM ET
$1.99
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Market Data
Market Cap $3.77M
Enterprise Value $3.78M
Beta 1.64
Average Volume 21.01K
Shares Outstanding (Diluted) 1.28M
Shares Change YoY 18.05%
Institutional Ownership 1.56%
Exchange NASDAQ
ISIN IL0011809592
Price Performance
Price Change 1M -55.1%
Price Change 3M -78.6%
Price Change 6M -88.9%
Price Change YTD -87.1%
Price Change 1Y -91.1%
Price Change 3Y -78.4%
Price Change 5Y N/A
1M CAGR (ann.) -68.7%
1Y CAGR (ann.) -90.6%
5Y CAGR (ann.) N/A
All-Time CAGR -53.1%
Valuation
PE Ratio -0.22
Forward PE N/A
PEG Ratio -0.08
Forward PEG 0.01
PS Ratio N/A
Forward PS 1.20
PB Ratio -2.42
P/FCF Ratio -1.03
P/Adj. FCF Ratio -0.69
P/OCF Ratio -0.69
EV/Sales N/A
EV/EBIT -0.34
EV/EBITDA -0.34
EV/FCF -1.03
Earnings Yield -447.7%
FCF Yield -97.4%
Adj. FCF Yield -146.0%
Financial Health
Net Cash $166K
Total Debt $170K
Cash & Short-Term Investments $166K
Total Assets $1.03M
Current Ratio 0.28
Quick Ratio 0.28
Debt / Equity Ratio 0.00
Debt / EBITDA -0.02
Debt / FCF -0.05
OCF / Debt -21.61
Interest Coverage -1,028.12
Altman Z-Score -102.30
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -49.9%
Returns
Return on Assets -978.9%
Return on Equity 611.0%
Return on Invested Capital 415.6%
Return on Capital Employed 415.6%
Return on Tangible Assets -978.9%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 26.4%
EPS CAGR 5Y 4.3%
EPS CAGR 10Y N/A
FCF CAGR 3Y -150.0%
FCF CAGR 5Y -100.0%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 2
EPS Growth Next 3Y 82.7%
Revenue Growth Next 3Y N/A
Earnings Date Sep 25, 2026
EPS Estimate (next Q) -$3.90
EPS Growth Est (next Q) N/A
Revenue Est (next Q) $535.6K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $33.00
Price Target Upside 1558.3%
Cash Flow
Operating Cash Flow $-3.67M
Free Cash Flow $-3.68M
Adj. Free Cash Flow $-5.51M
FCF Per Share -$2.88
OCF Per Share -$2.87
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-11.09M
EBITDA $-11.07M
Net Income $-11.13M
EPS (Diluted) -$8.91
Revenue / Employee N/A
Profit / Employee $-654.41K
Employees 17
Add to Watchlist
Select watchlists to add or remove NRSN